URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Louis Constine

Concepts (482)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Hodgkin Disease
38
1982
153
7.210
Why?
Neoplasms, Second Primary
17
2000
124
4.310
Why?
Radiotherapy
31
1981
198
4.200
Why?
Radiation Injuries
21
1988
130
4.010
Why?
Neoplasms
21
1981
723
2.750
Why?
Survivors
17
1993
114
2.440
Why?
Sarcoma
5
1992
63
2.340
Why?
Antineoplastic Combined Chemotherapy Protocols
16
1985
430
2.200
Why?
Cardiovascular Diseases
11
2003
276
1.860
Why?
Neoplasms, Radiation-Induced
11
1995
78
1.700
Why?
Stem Cell Transplantation
3
1999
113
1.450
Why?
Neoplasm Recurrence, Local
8
1995
286
1.450
Why?
Child
52
1973
4086
1.440
Why?
Soft Tissue Neoplasms
3
1992
46
1.410
Why?
Radiotherapy Dosage
22
1981
203
1.380
Why?
Lung Neoplasms
6
1985
428
1.330
Why?
Humans
116
1973
36400
1.300
Why?
Aging
5
2006
706
1.230
Why?
Adolescent
45
1981
4752
1.210
Why?
Combined Modality Therapy
24
1984
486
1.160
Why?
Adult
51
1981
11345
1.130
Why?
Breast Neoplasms
8
2008
675
1.020
Why?
Bone Marrow Transplantation
8
1984
186
1.010
Why?
Hematopoietic Stem Cell Transplantation
4
1998
117
1.010
Why?
Whole-Body Irradiation
7
1984
82
0.970
Why?
Child, Preschool
31
1973
2612
0.930
Why?
Young Adult
16
2009
1074
0.930
Why?
Heart
5
1995
242
0.920
Why?
Radiation Oncology
5
2008
18
0.890
Why?
Risk Factors
20
1991
2318
0.860
Why?
Female
69
1973
19826
0.840
Why?
Lymphoma, Large B-Cell, Diffuse
2
2009
78
0.840
Why?
Antineoplastic Agents
11
1985
625
0.810
Why?
Male
57
1973
19713
0.800
Why?
Brain Neoplasms
5
1987
282
0.790
Why?
Central Nervous System Neoplasms
2
1999
21
0.780
Why?
Fractures, Spontaneous
1
2010
15
0.760
Why?
Cell Aging
2
2010
57
0.740
Why?
Leg
1
2010
97
0.730
Why?
Graft vs Host Disease
3
1999
81
0.720
Why?
Radiosurgery
1
2011
74
0.710
Why?
Incidence
10
1995
679
0.710
Why?
Bone Density
1
2010
115
0.710
Why?
Cell Transformation, Neoplastic
2
2010
136
0.710
Why?
Radiation Tolerance
9
1981
89
0.670
Why?
Middle Aged
30
1987
9877
0.670
Why?
Anthracyclines
5
2007
15
0.660
Why?
DNA Repair
1
2010
174
0.640
Why?
Heart Diseases
4
1995
145
0.630
Why?
Neoplasm Staging
12
1985
335
0.610
Why?
Dose-Response Relationship, Radiation
14
1984
218
0.600
Why?
Practice Guidelines as Topic
4
2008
304
0.590
Why?
Skin Diseases
1
2008
119
0.590
Why?
Tomography, X-Ray Computed
8
1988
765
0.580
Why?
Follow-Up Studies
16
1984
1857
0.580
Why?
Aged
19
1987
7272
0.580
Why?
Leukemia, Myeloid, Acute
1
2008
179
0.560
Why?
Stereotaxic Techniques
1
2006
33
0.560
Why?
Radiology
3
1992
29
0.560
Why?
Time Factors
15
1982
3201
0.560
Why?
Disease
1
2006
36
0.540
Why?
Liver Neoplasms
2
2006
152
0.540
Why?
Dose Fractionation
4
2006
58
0.540
Why?
Risk Assessment
8
2004
878
0.530
Why?
Survival Analysis
10
1993
598
0.530
Why?
Survival Rate
13
1990
619
0.530
Why?
Thyroid Neoplasms
5
1995
65
0.530
Why?
Infant
13
1981
2249
0.520
Why?
Transplantation, Autologous
7
1984
144
0.520
Why?
Diagnostic Imaging
5
1995
86
0.520
Why?
Glioma
2
1987
102
0.500
Why?
Amifostine
4
1985
28
0.490
Why?
Hypothyroidism
6
1982
43
0.480
Why?
Bone Marrow
6
1984
290
0.480
Why?
Treatment Outcome
12
1996
2623
0.470
Why?
Antibiotics, Antineoplastic
3
1993
48
0.470
Why?
Optic Nerve Neoplasms
1
2003
2
0.460
Why?
Neurofibromatosis 1
1
2003
7
0.460
Why?
Endocrine System Diseases
3
1997
11
0.430
Why?
Salvage Therapy
3
2009
60
0.430
Why?
Recurrence
6
1997
697
0.410
Why?
Thyroid Gland
3
1993
53
0.410
Why?
Medical Oncology
2
1992
49
0.390
Why?
Radiation-Protective Agents
3
1986
41
0.390
Why?
Population Surveillance
4
2001
137
0.390
Why?
Prognosis
9
1996
1080
0.360
Why?
Antibodies, Monoclonal, Murine-Derived
2
2009
132
0.360
Why?
Cyclophosphamide
6
1998
173
0.360
Why?
Models, Statistical
3
2010
219
0.350
Why?
Thymus Gland
2
2010
143
0.350
Why?
Rhabdoid Tumor
1
1999
5
0.350
Why?
Ventriculoperitoneal Shunt
1
1999
11
0.350
Why?
Peritoneal Neoplasms
1
1999
26
0.340
Why?
Pituitary Neoplasms
2
1989
66
0.330
Why?
Hypothalamo-Hypophyseal System
2
1995
55
0.320
Why?
Neoadjuvant Therapy
2
2007
32
0.310
Why?
Age Distribution
4
2010
216
0.310
Why?
Lung Diseases
3
2006
224
0.310
Why?
Sex Factors
7
1975
584
0.300
Why?
Retrospective Studies
8
1985
2260
0.300
Why?
Age Factors
9
1973
1121
0.300
Why?
Organothiophosphorus Compounds
2
1986
8
0.300
Why?
Severity of Illness Index
3
1995
919
0.290
Why?
Models, Biological
4
1988
1023
0.280
Why?
Methotrexate
3
1990
71
0.280
Why?
Transplantation, Homologous
4
1999
260
0.280
Why?
Cell Proliferation
2
2010
521
0.270
Why?
Rhabdomyosarcoma
1
1995
12
0.270
Why?
Cranial Irradiation
3
1990
12
0.270
Why?
Magnetic Resonance Imaging
5
1988
1010
0.260
Why?
Medulloblastoma
3
1987
19
0.260
Why?
Thyroid Diseases
1
1995
20
0.260
Why?
Cerebellar Neoplasms
3
1987
22
0.260
Why?
Siblings
2
2010
33
0.260
Why?
Fibroblast Growth Factor 2
3
1998
84
0.260
Why?
Lymphoma, Non-Hodgkin
2
1997
113
0.250
Why?
Lymphoma
2
1998
163
0.250
Why?
Clinical Trials as Topic
6
1985
675
0.250
Why?
Doxorubicin
4
1990
109
0.240
Why?
Disease-Free Survival
6
1998
202
0.240
Why?
Head and Neck Neoplasms
1
1995
84
0.240
Why?
Radiation Dosage
6
1993
126
0.240
Why?
Radiotherapy, Adjuvant
3
1998
73
0.230
Why?
Bone Development
2
1987
81
0.220
Why?
Morbidity
2
2009
71
0.220
Why?
Pituitary Gland
1
1993
62
0.220
Why?
Hypothalamus
1
1993
89
0.220
Why?
Gonadal Disorders
1
2012
1
0.220
Why?
Reproductive Health
1
2012
1
0.220
Why?
Guideline Adherence
2
2010
83
0.220
Why?
Gastrointestinal Neoplasms
1
2012
21
0.210
Why?
Hyperprolactinemia
2
1987
7
0.210
Why?
Vincristine
3
1990
61
0.210
Why?
Brain
2
1988
1221
0.210
Why?
Carcinoma, Ductal, Breast
2
2008
39
0.210
Why?
Quality Assurance, Health Care
2
2009
119
0.210
Why?
Echocardiography
2
1993
232
0.210
Why?
Histiocytoma, Malignant Fibrous
1
2011
5
0.200
Why?
Colony-Forming Units Assay
1
1991
40
0.200
Why?
United States
7
1992
2630
0.200
Why?
Sarcoma, Synovial
1
2011
7
0.200
Why?
Aged, 80 and over
5
1992
2513
0.200
Why?
Leiomyosarcoma
1
2011
18
0.200
Why?
Databases, Factual
2
1999
151
0.190
Why?
Remission Induction
2
1997
163
0.190
Why?
Adiposity
1
2010
10
0.190
Why?
Growth Plate
2
2001
142
0.190
Why?
Weight-Bearing
1
2010
45
0.190
Why?
Cytoprotection
1
2010
41
0.190
Why?
Carcinoma, Non-Small-Cell Lung
1
2011
71
0.190
Why?
Prednisone
2
1998
177
0.180
Why?
Predictive Value of Tests
5
1999
601
0.180
Why?
Meta-Analysis as Topic
1
2010
35
0.180
Why?
Information Dissemination
1
2010
24
0.180
Why?
Clinical Protocols
1
2010
105
0.180
Why?
Osteonecrosis
1
2010
24
0.180
Why?
Chronic Disease
2
1991
530
0.180
Why?
Interleukin-1
1
1991
222
0.180
Why?
Testicular Neoplasms
1
2010
54
0.180
Why?
Chemotherapy, Adjuvant
2
1996
88
0.180
Why?
Infertility
2
2006
22
0.180
Why?
Thyroid Hormones
2
1984
35
0.180
Why?
Brain Injuries
1
2011
109
0.180
Why?
Intelligence
1
1990
108
0.170
Why?
Antibodies, Monoclonal
3
1985
732
0.170
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
1990
77
0.170
Why?
Craniopharyngioma
1
1989
5
0.170
Why?
Fractures, Bone
1
2010
93
0.170
Why?
Health Status
1
2012
269
0.170
Why?
Homeostasis
1
2010
177
0.170
Why?
DNA Damage
1
2010
167
0.170
Why?
Splenectomy
1
2008
37
0.170
Why?
Abdominal Neoplasms
1
2008
17
0.160
Why?
Leukemia
2
1999
154
0.160
Why?
Carmustine
4
1987
37
0.160
Why?
Biopsy, Fine-Needle
1
2008
21
0.160
Why?
Analysis of Variance
2
1999
725
0.160
Why?
Carcinoid Tumor
1
2008
26
0.160
Why?
Carcinoma in Situ
1
2008
41
0.160
Why?
Neoplasm Metastasis
2
1985
229
0.160
Why?
Adenoma
1
2008
53
0.160
Why?
Glioblastoma
3
1988
63
0.160
Why?
Quality of Life
3
2005
509
0.160
Why?
Statistics as Topic
1
2008
187
0.160
Why?
Etoposide
5
1998
83
0.150
Why?
Regeneration
2
1984
60
0.150
Why?
Razoxane
1
2007
8
0.150
Why?
Biomedical Research
1
2009
140
0.150
Why?
Pediatrics
1
1992
390
0.150
Why?
Patient Care Planning
1
2007
71
0.150
Why?
SEER Program
3
2010
52
0.150
Why?
Chelating Agents
1
2007
67
0.150
Why?
Aging, Premature
1
2006
7
0.140
Why?
Delivery of Health Care
1
2008
145
0.140
Why?
Tumor Burden
1
2006
23
0.140
Why?
Radiotherapy, Computer-Assisted
1
2006
15
0.140
Why?
Leukemia, Myeloid
1
2007
122
0.140
Why?
Odds Ratio
3
2010
304
0.140
Why?
Cohort Studies
4
2007
969
0.140
Why?
Oxidative Stress
1
2010
352
0.140
Why?
Cartilage
1
1987
158
0.140
Why?
Transplantation Conditioning
2
1999
31
0.130
Why?
Foundations
1
2005
12
0.130
Why?
Myelodysplastic Syndromes
1
2007
133
0.130
Why?
Apoptosis
2
2002
855
0.130
Why?
Radiotherapy Planning, Computer-Assisted
3
2008
48
0.130
Why?
Adenocarcinoma
1
2008
423
0.130
Why?
Nervous System Diseases
1
2006
147
0.120
Why?
Skin
1
1987
381
0.120
Why?
Thyrotropin
3
1982
32
0.120
Why?
Puberty, Precocious
2
1995
4
0.120
Why?
Cardiomyopathies
2
1993
85
0.120
Why?
Hematopoietic Stem Cells
4
1984
190
0.120
Why?
Ventricular Function, Left
2
1990
98
0.120
Why?
Animals
15
1981
16270
0.120
Why?
Optic Chiasm
1
2003
7
0.110
Why?
Coronary Disease
2
1995
266
0.110
Why?
Cognition Disorders
1
2007
278
0.110
Why?
Prostatic Neoplasms
2
1985
556
0.110
Why?
Mediastinum
1
2003
18
0.110
Why?
Infant, Newborn
5
1981
1831
0.110
Why?
Stomatitis
2
1999
15
0.110
Why?
Fibrosis
2
1995
65
0.110
Why?
Visual Pathways
1
2003
78
0.110
Why?
Pentoxifylline
1
2002
27
0.100
Why?
Mental Disorders
1
2006
346
0.100
Why?
Platinum Compounds
2
2010
7
0.100
Why?
Rabbits
4
1984
704
0.100
Why?
European Continental Ancestry Group
2
1996
226
0.100
Why?
Myocardial Infarction
3
1996
681
0.100
Why?
Infertility, Male
2
2010
36
0.100
Why?
Growth
1
1981
38
0.100
Why?
Astrocytoma
2
1988
30
0.100
Why?
Transforming Growth Factor beta
2
1998
413
0.090
Why?
Myocardium
2
1995
325
0.090
Why?
Dose-Response Relationship, Drug
4
1987
1138
0.090
Why?
Hyperthyroidism
2
1982
24
0.090
Why?
Coronary Artery Disease
2
2010
96
0.090
Why?
Exercise Test
2
1993
105
0.090
Why?
Parenteral Nutrition
1
1999
23
0.090
Why?
Nifedipine
1
1999
33
0.090
Why?
Cytarabine
3
1998
91
0.090
Why?
Ring Chromosomes
1
1999
5
0.090
Why?
Methylprednisolone
1
1999
44
0.090
Why?
Chromosomes, Human, Pair 22
1
1999
11
0.090
Why?
Mouth Mucosa
1
1999
42
0.090
Why?
Cyclosporine
1
1999
63
0.090
Why?
Models, Animal
2
2010
138
0.090
Why?
Calcium Signaling
1
2002
191
0.090
Why?
Calcium Channel Blockers
1
1999
69
0.090
Why?
Case-Control Studies
2
2010
618
0.080
Why?
Chondrocytes
1
2002
291
0.080
Why?
Pituitary Hormones
2
1995
13
0.080
Why?
Research
2
2010
179
0.080
Why?
Genetic Predisposition to Disease
2
2010
329
0.080
Why?
Cause of Death
3
1990
159
0.080
Why?
Exercise Tolerance
1
1997
11
0.080
Why?
Diastole
1
1997
27
0.080
Why?
Immunosuppressive Agents
1
1999
196
0.080
Why?
Bone Neoplasms
2
1985
206
0.080
Why?
Radiation Pneumonitis
2
2007
44
0.080
Why?
Risk
2
2007
358
0.080
Why?
Bleomycin
3
1990
46
0.080
Why?
Fatigue
2
2007
125
0.080
Why?
Neovascularization, Physiologic
1
1998
126
0.080
Why?
Stroke Volume
1
1997
161
0.070
Why?
Gene Expression Regulation
1
2002
875
0.070
Why?
Evidence-Based Medicine
2
2004
199
0.070
Why?
Reproducibility of Results
2
2008
884
0.070
Why?
Ploidies
1
1995
18
0.070
Why?
Multicenter Studies as Topic
1
1996
128
0.070
Why?
Genes, myc
1
1995
26
0.070
Why?
Drug Resistance, Multiple
1
1995
30
0.070
Why?
Pituitary Hormones, Anterior
1
1995
5
0.070
Why?
Pericardium
1
1995
16
0.070
Why?
Genes, Tumor Suppressor
1
1995
49
0.070
Why?
Follicle Stimulating Hormone
1
1995
50
0.070
Why?
African Continental Ancestry Group
1
1996
121
0.060
Why?
Bone and Bones
1
1998
357
0.060
Why?
Growth Hormone
1
1995
103
0.060
Why?
Luteinizing Hormone
1
1995
58
0.060
Why?
Adrenocorticotropic Hormone
1
1995
75
0.060
Why?
Injury Severity Score
1
1995
72
0.060
Why?
Neuroblastoma
2
1985
93
0.060
Why?
Proportional Hazards Models
2
1996
453
0.060
Why?
Cell Cycle
1
1995
248
0.060
Why?
Prospective Studies
3
1993
1677
0.060
Why?
Mice
7
1981
6103
0.060
Why?
Randomized Controlled Trials as Topic
1
1996
409
0.060
Why?
Gonads
1
1993
6
0.060
Why?
Supratentorial Neoplasms
1
1993
8
0.060
Why?
Hypogonadism
1
1993
14
0.060
Why?
Adrenal Glands
1
1993
52
0.050
Why?
Positron-Emission Tomography and Computed Tomography
1
2012
1
0.050
Why?
Multivariate Analysis
2
1990
531
0.050
Why?
Semen Preservation
1
2012
2
0.050
Why?
Puberty, Delayed
1
2012
3
0.050
Why?
Procarbazine
1
2012
12
0.050
Why?
Sexual Dysfunction, Physiological
1
2012
12
0.050
Why?
Laparotomy
1
1992
36
0.050
Why?
Cryopreservation
1
2012
26
0.050
Why?
Natriuretic Peptide, Brain
1
2012
11
0.050
Why?
Canada
1
2012
76
0.050
Why?
Radiotherapy, Intensity-Modulated
1
2012
7
0.050
Why?
Acute Disease
2
2000
580
0.050
Why?
Confounding Factors (Epidemiology)
1
2012
58
0.050
Why?
Radiotherapy, Conformal
1
2012
19
0.050
Why?
Confidence Intervals
1
2012
165
0.050
Why?
Age of Onset
1
2012
122
0.050
Why?
Heart Block
1
2012
57
0.050
Why?
Parathyroid Hormone-Related Protein
2
2001
105
0.050
Why?
Matched-Pair Analysis
1
2011
17
0.050
Why?
Cholesterol
1
2012
139
0.050
Why?
Kaplan-Meier Estimate
1
2012
224
0.050
Why?
Outcome and Process Assessment (Health Care)
1
1992
84
0.050
Why?
Tumor Stem Cell Assay
1
1991
23
0.050
Why?
Testosterone
1
2012
165
0.050
Why?
Carcinoma, Lobular
1
2011
24
0.050
Why?
C-Reactive Protein
1
2012
119
0.050
Why?
Pancytopenia
1
2010
14
0.050
Why?
Maximum Tolerated Dose
1
2010
18
0.050
Why?
Melphalan
1
2010
27
0.050
Why?
Mucositis
1
2010
14
0.050
Why?
Lymph Nodes
1
1992
207
0.050
Why?
Peripheral Blood Stem Cell Transplantation
1
2010
21
0.050
Why?
Granulocytes
1
1991
84
0.050
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2011
40
0.050
Why?
Paresthesia
1
2010
16
0.050
Why?
Polymorphism, Genetic
1
2012
199
0.050
Why?
Colorectal Neoplasms
1
2012
136
0.050
Why?
Genome-Wide Association Study
1
2010
23
0.050
Why?
Radioactive Fallout
1
2010
2
0.050
Why?
Renal Insufficiency
1
2010
22
0.050
Why?
Pericarditis
1
2010
12
0.050
Why?
Coronary Circulation
1
1990
94
0.050
Why?
Stroke
1
2012
117
0.050
Why?
Injections, Spinal
1
1990
25
0.050
Why?
Employment
1
2010
68
0.050
Why?
Peptide Fragments
1
2012
301
0.050
Why?
Hypertrophy
1
2010
71
0.050
Why?
Societies, Medical
1
2011
139
0.050
Why?
Prednisolone
1
2009
25
0.040
Why?
Organ Specificity
1
2010
157
0.040
Why?
Arrhythmias, Cardiac
1
2012
248
0.040
Why?
Adipose Tissue
1
2010
137
0.040
Why?
Postoperative Complications
2
1992
743
0.040
Why?
Forecasting
1
2010
178
0.040
Why?
Pulmonary Fibrosis
1
2010
140
0.040
Why?
Atrial Fibrillation
1
2010
115
0.040
Why?
Body Mass Index
1
2010
211
0.040
Why?
Translational Medical Research
1
2009
38
0.040
Why?
Disease Progression
1
2011
519
0.040
Why?
Radiobiology
1
2008
10
0.040
Why?
Biological Markers
1
2012
564
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2001
543
0.040
Why?
Occupational Exposure
1
2010
112
0.040
Why?
Proteins
2
2001
467
0.040
Why?
Radiation Injuries, Experimental
1
1988
88
0.040
Why?
Cognition
1
2010
227
0.040
Why?
Rats
2
1981
4386
0.040
Why?
Spinal Cord
1
1988
164
0.040
Why?
Leukemia, Radiation-Induced
1
2007
11
0.040
Why?
Palliative Care
2
1985
159
0.040
Why?
Topoisomerase II Inhibitors
1
2007
8
0.040
Why?
Antineoplastic Agents, Alkylating
1
2007
41
0.040
Why?
Time
1
2007
46
0.040
Why?
Meningeal Neoplasms
1
1987
51
0.040
Why?
Meningioma
1
1987
54
0.040
Why?
Osteosarcoma
1
2007
71
0.040
Why?
Reference Values
1
2007
441
0.030
Why?
Italy
1
2005
21
0.030
Why?
Radiation-Sensitizing Agents
2
1982
72
0.030
Why?
Mice, Inbred C57BL
1
1991
1683
0.030
Why?
Sarcoma, Ewing
1
1985
10
0.030
Why?
Wilms Tumor
1
1985
11
0.030
Why?
Antigens, Neoplasm
1
1986
107
0.030
Why?
Nursing Care
1
2004
15
0.030
Why?
Congenital Abnormalities
1
1985
38
0.030
Why?
Skin Physiological Phenomena
2
1973
19
0.030
Why?
Enzyme Inhibitors
1
2007
438
0.030
Why?
RNA, Messenger
2
2001
1857
0.030
Why?
Thyroxine
1
1984
46
0.030
Why?
Joints
2
1973
61
0.030
Why?
Kidney Neoplasms
1
1985
102
0.030
Why?
Cell Separation
1
1984
227
0.030
Why?
Longitudinal Studies
1
2004
390
0.030
Why?
Nitroimidazoles
1
1982
11
0.030
Why?
Neck
1
1982
34
0.030
Why?
Genes, bcl-2
1
2002
23
0.030
Why?
Research Design
1
2004
333
0.030
Why?
Drug Evaluation, Preclinical
1
2002
79
0.030
Why?
Chick Embryo
1
2002
187
0.030
Why?
Receptors, Parathyroid Hormone
1
2001
14
0.030
Why?
Receptor, Parathyroid Hormone, Type 1
1
2001
24
0.020
Why?
Cytosol
1
2002
194
0.020
Why?
Proto-Oncogene Proteins c-bcl-2
1
2002
119
0.020
Why?
Sodium Pertechnetate Tc 99m
1
2000
9
0.020
Why?
Chickens
1
2001
307
0.020
Why?
Radiopharmaceuticals
1
2000
49
0.020
Why?
Myeloablative Agonists
1
2000
6
0.020
Why?
Nuclear Family
1
2000
12
0.020
Why?
Drug Toxicity
1
2000
16
0.020
Why?
Drug Evaluation
1
2000
101
0.020
Why?
Blood Grouping and Crossmatching
1
2000
32
0.020
Why?
Protein Biosynthesis
1
2002
265
0.020
Why?
DNA Primers
1
2001
414
0.020
Why?
Wiskott-Aldrich Syndrome
1
1999
7
0.020
Why?
Anemia, Aplastic
1
1999
25
0.020
Why?
Life Tables
1
1999
39
0.020
Why?
Gestational Age
1
1981
341
0.020
Why?
Fetus
1
1981
257
0.020
Why?
Graft Survival
1
2000
145
0.020
Why?
Diarrhea
1
1999
64
0.020
Why?
Hematologic Neoplasms
1
1999
31
0.020
Why?
Cell Division
1
2002
766
0.020
Why?
Lymphotoxin-alpha
1
1998
11
0.020
Why?
Laser-Doppler Flowmetry
1
1998
20
0.020
Why?
Carcinoma
1
2000
191
0.020
Why?
Drug Therapy, Combination
1
1999
390
0.020
Why?
Mice, Inbred BALB C
3
1982
621
0.020
Why?
Mice, Inbred C3H
1
1998
229
0.020
Why?
Regional Blood Flow
1
1998
190
0.020
Why?
Neoplasm, Residual
1
1997
20
0.020
Why?
Base Sequence
1
2001
1704
0.020
Why?
Pilot Projects
2
1985
441
0.020
Why?
Karnofsky Performance Status
1
1996
15
0.020
Why?
Information Systems
1
1996
16
0.020
Why?
Movement
2
1973
165
0.020
Why?
Hematopoietic Cell Growth Factors
1
1995
16
0.020
Why?
Bone Marrow Diseases
1
1995
44
0.020
Why?
Fluorescent Antibody Technique
2
1985
291
0.020
Why?
Calcium
1
2002
1127
0.020
Why?
Dogs
1
1995
488
0.020
Why?
Terminology as Topic
1
1995
107
0.020
Why?
Tumor Necrosis Factor-alpha
1
1998
695
0.010
Why?
Immunoglobulin G
2
1985
482
0.010
Why?
Gallium Radioisotopes
1
1992
8
0.010
Why?
Evaluation Studies as Topic
1
1992
243
0.010
Why?
Neoplasm Invasiveness
1
1992
154
0.010
Why?
Postoperative Period
1
1992
85
0.010
Why?
Biopsy
1
1992
359
0.010
Why?
Spleen
1
1992
339
0.010
Why?
Vinblastine
1
1990
27
0.010
Why?
Dacarbazine
1
1990
21
0.010
Why?
Heart Function Tests
1
1990
33
0.010
Why?
Surgical Procedures, Operative
1
1992
114
0.010
Why?
Drug Administration Schedule
1
1990
369
0.010
Why?
Sensitivity and Specificity
1
1992
905
0.010
Why?
Electrocardiography
1
1993
782
0.010
Why?
Liver
1
1992
876
0.010
Why?
Hybridomas
1
1986
65
0.010
Why?
Antigen-Antibody Complex
1
1986
55
0.010
Why?
Premedication
1
1985
21
0.010
Why?
Carcinoma, Small Cell
1
1985
32
0.010
Why?
Myeloma Proteins
1
1985
11
0.010
Why?
Urinary Tract
1
1985
9
0.010
Why?
Binding Sites, Antibody
1
1985
32
0.010
Why?
Antibody-Dependent Cell Cytotoxicity
1
1985
28
0.010
Why?
Centrifugation
1
1984
45
0.010
Why?
Erythrocyte Count
1
1984
27
0.010
Why?
Skinfold Thickness
2
1973
8
0.010
Why?
London
2
1973
19
0.010
Why?
Complement System Proteins
1
1985
112
0.010
Why?
Leukocyte Count
1
1984
159
0.010
Why?
Elasticity
2
1973
83
0.010
Why?
Immunoenzyme Techniques
1
1985
220
0.010
Why?
Central Nervous System
1
1985
117
0.010
Why?
Lung
1
1990
1142
0.010
Why?
Bone Marrow Cells
1
1985
223
0.010
Why?
Cell Survival
1
1985
561
0.010
Why?
Etanidazole
1
1982
24
0.010
Why?
Chemistry, Pharmaceutical
1
1982
22
0.010
Why?
Injections, Intravenous
1
1982
131
0.010
Why?
Administration, Oral
1
1982
309
0.010
Why?
Cell Line
1
1986
1594
0.010
Why?
Kinetics
1
1982
1464
0.010
Why?
Metacarpus
1
1975
4
0.000
Why?
Knee
1
1975
23
0.000
Why?
Elbow
1
1975
16
0.000
Why?
Ankle
1
1975
22
0.000
Why?
Finger Joint
1
1975
28
0.000
Why?
Wrist
1
1975
49
0.000
Why?

Visualizations


Constine's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department